AJU IB Investment Company’s Xilio Therapeutics XLO Stock Holding History

AJU IB Investment Company’s Portfolio XLO Stock Details XLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,695	Closed	-$401K	–	6
2026 Q1	$401K	Sell	47,695 -1	-0%	-$8	1.31%	6
2025 Q4	$427K	Hold	47,696	–	–	1.88%	5
2025 Q3	$596K	Hold	47,696	–	–	0.52%	4
2025 Q2	$454K	Hold	47,696	–	–	0.49%	4
2025 Q1	$484K	Hold	47,696	–	–	0.58%	5
2024 Q4	$638K	Buy	+47,696	New	+$656K	0.62%	5
2022 Q3	$1.94M	Hold	47,696	–	–	3.33%	6
2022 Q2	$1.95M	Hold	47,696	–	–	3.78%	5
2022 Q1	$4.72M	Hold	47,696	–	–	7.29%	5
2021 Q4	$10.7M	Buy	+47,696	New	+$11.4M	14.88%	3

Other funds holding XLO

KFI

Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return

AJU IB Investment Company's XLO Position: Q2 2026 in Review

AJU IB Investment Company sold out of Xilio Therapeutics (XLO) in Q2 2026, closing a stake of 47,695 shares — an estimated $401K sold.

AJU IB Investment Company first reported a position in XLO in Q4 2021 and held it in 10 quarters. The position peaked at $10.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds XLO as of Q2 2026.

AJU IB Investment Company reported no remaining Xilio Therapeutics position as of Q2 2026 after selling out during the quarter.
AJU IB Investment Company sold 47,695 Xilio Therapeutics shares in Q2 2026, an estimated $401K.
AJU IB Investment Company first reported a position in Xilio Therapeutics in Q4 2021 and held it in 10 quarters.
AJU IB Investment Company's Xilio Therapeutics position peaked at $10.7M in Q4 2021.
1 fund tracked by Wall St. Rank held Xilio Therapeutics as of Q2 2026.

Based on AJU IB Investment Company's 13F filing for Q2 2026.